FSCN1 promotes proliferation, invasion and glycolysis via the IRF4/AKT signaling pathway in oral squamous cell carcinoma

被引:0
作者
Liang Li
Lihui Chen
Zhangwei Li
Shiqin Huang
Yaoyao Chen
Zhiyong Li
Wenkuan Chen
机构
[1] the First Affiliated Hospital of Guangdong Pharmaceutical University,Department of Stomatology
[2] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China
来源
BMC Oral Health | / 23卷
关键词
FSCN1; IRF4; AKT; OSCC; Proliferation; Invasion; Glycolysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 166 条
[1]  
Bugshan A(2020)Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis F1000Res 9 229-7
[2]  
Farooq I(2018)Perspectives on oral squamous cell carcinoma prevention-proliferation, position, progression and prediction J Oral Pathol Med 47 803-39
[3]  
Thomson PJ(2022)FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance J Cancer 13 2528-300
[4]  
Li Z(2011)The roles of fascins in health and disease J Pathol 224 289-64
[5]  
Shi J(2021)Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target? Mol Ther Oncolytics 20 240-77
[6]  
Zhang N(2021)Fascin in Gynecological Cancers: an update of the literature Cancers (Basel) 13 22-64
[7]  
Zheng X(2018)FSCN1 promotes epithelial-mesenchymal transition through increasing Snail1 in Ovarian Cancer cells Cell Physiol Biochem 49 1766-21
[8]  
Jin Y(2018)FSCN1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition Int J Oncol 52 1455-88
[9]  
Wen S(2018)Application of weighted gene co-expression network analysis to identify key modules and hub genes in oral squamous cell carcinoma tumorigenesis Onco Targets Ther 11 6001-82
[10]  
Hashimoto Y(2019)Weighted gene Co-Expression Network Analysis identifies hub genes Associated with occurrence and prognosis of oral squamous cell carcinoma Med Sci Monit 25 7272-84